BiomX Inc.
PHGE
$0.601
-$0.01-1.64%
AMEX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -17.73M | -8.71M | -26.25M | -37.14M | -26.17M |
Total Depreciation and Amortization | 1.80M | 1.09M | 991.00K | 877.00K | 871.00K |
Total Amortization of Deferred Charges | -- | 114.00K | 236.00K | 499.00K | 567.00K |
Total Other Non-Cash Items | -18.06M | -23.44M | -4.56M | 9.37M | 969.00K |
Change in Net Operating Assets | -2.99M | -5.99M | -5.17M | -1.21M | 2.48M |
Cash from Operations | -36.98M | -36.93M | -34.76M | -27.60M | -21.29M |
Capital Expenditure | -30.00K | -26.00K | -48.00K | -40.00K | -50.00K |
Sale of Property, Plant, and Equipment | 82.00K | 73.00K | 64.00K | 1.00K | 1.00K |
Cash Acquisitions | 663.00K | 663.00K | 663.00K | 663.00K | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | 2.00M |
Cash from Investing | 715.00K | 710.00K | 679.00K | 624.00K | 1.95M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -10.75M | -12.07M | -13.35M | -14.58M | -4.25M |
Issuance of Common Stock | 25.00K | 25.00K | 25.00K | 6.04M | 7.49M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | 21.27M | 21.27M | 21.27M | 21.27M | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 27.83M | 28.23M | 28.19M | 28.10M | -333.00K |
Cash from Financing | 38.37M | 37.45M | 36.14M | 40.82M | 2.90M |
Foreign Exchange rate Adjustments | 1.00K | 32.00K | -11.00K | -38.00K | 6.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 2.11M | 1.26M | 2.05M | 13.81M | -16.43M |